The usefulness of 99mtc tetrofosmin scintigraphy in patients with breast cancer recurrences

Nuclear Medicine Communications

Volumn 24, Issue 2, 2003, Pages 145-154

  Spanu, A ^a   Farris, A ^a   Schillaci, O ^a   Chessa, F ^a   Solinas, M E ^a   Falchi, A ^a   Madeddu, Gr ^a   Nuvoli, S ^a   Madeddu, G ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

99mTc tetrofosmin; Breast cancer; Follow up; SPET

Indexed keywords

DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BONE TUMOR; BRAIN TUMOR; BREAST; BREAST TUMOR; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; LABORATORY DIAGNOSIS; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; BRAIN NEOPLASMS; BREAST; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 85045482237     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200302000-00007     Document Type: Article

References (29)

1. Rosen P, Groshen W, Saigo P, Kime DW, Hellman S. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol 1989; 7: 355-366.
2. Fisher E, Sass R, Fisher B. Pathologic findings from the National Surgical Adjuvant Project for breast cancers (protocol no. 4). Cancer 1984; 53: 712-723.
3. Osborne CK. Prognostic factors for breast cancer: have they met their promise? J Clin Oncol 1992; 10: 679-682.
4. Hannisdal E, Gundersen S, Kvaloy S, Lindegaard MW, Aas M, Finnager AM, et al. Follow-up of breast cancer patients stage I-II: a baseline strategy. Eur J Cancer 1993; 29A: 992-997.
5. Berg JW, Robbins GF. Factors influencing short and long-term survival of breast cancer patients. Surg Gynecol Obstet 1996; 122: 1311-1316.
6. Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER, Cruz AB, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: an NSABP update. Cancer 1983; 52: 1551-1557.
7. Saez RA, Clark GM, McGuire WL. Prognostic factors in breast cancer. Semin Surg Oncol 1989; 5: 102-110.
8. Moon DH, Maddahi J, Silverman DHS, Glaspy JA, Phelps ME, Hoh CK. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma. J Nucl Med 1998; 39: 431-435.
9. Hathaway PB, Mankoff DA, Maravilla KR, Austin-Seymour MM, Ellis GK, Gralow JR, et al. Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience. Radiology 1999; 210: 807-814.
10. Kim TS, Moon WK, Lee DS, Chung JK, Lee MC, Youn YK, et al. Fluorodeoxyglucose positron emission tomography for detection of recurrent or metastatic breast cancer. World J Surg 2001; 25: 829-834.
11. Eubank WB, Mankoff DA, Vesselle HJ, Eary JF, Schubert EK, Dunnwald LK, et al. Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET. Radiographics 2002; 22: 5-17.
12. Bender H, Kirst J, Palmedo H, Schomburg A, Wagner U, Ruhlmann J, et al. Value of 18fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma. Anticancer Res 1997; 17: 1687-1692.
13. Trampal C, Maldonado A, Sancho Cuesta F, Morales S, Senor de Uria C, Panades G, et al. Role of the positron emission tomography (PET) in suspected tumor recurrence when there is increased serum tumor markers. Rev Esp Med Nucl 2000; 19: 279-287.
14. Yildiz A, Garipa_ao_lu M, Güngör F, Boz A, Dalmaz G. The role of technetium-99m methoxyisobutyl isonitrile scintigraphy in suspected recurrent breast cancer. Cancer Biother Radiopharm 2001; 16: 163-169.
15. Cwikla JB, Kolasinska A, Buscombe JR, Hilson AJ. Tc-99m MIBI in suspected recurrent breast cancer. Cancer Biother Radiopharm 2000; 15: 367-372.
16. Katayama N, Inoue Y, Ichikawa T, Harada M, Itoh T, Shimoyamada K, et al. Local recurrence of breast cancer demonstrated on 99mTc-MIBI scintigraphy. Radiat Med 1999; 17: 389-391.
17. Kunh JC, Siegel A, Poplak S, Arrick B. Chest wall recurrence of breast cancer detected by scintimammography. Clin Nucl Med 2000; 25: 104-106.
18. Bernard BF, Krenning EP, Breeman WA, Ensing G, Benjamins H, Bakker WH, et al. 99mTc-MIBI, 99mTc-tetofosmin and 99mTc-Q12 in vitro and in vivo. Nucl Med Biol 1998; 25: 233-240.
19. Ballinger JR, Bannerman J, Boxen I, Firby P, Hartman NG, Moore MJ. Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cells. J Nucl Med 1996; 37: 1578-1582.
20. 99mTc-Q12 into human breast cancer cell lines. Eur J Nucl Med 1996; 23: 1361-1366.
21. m-tetrofosmin scintigraphy in the evaluation of palpable breast masses. Nucl Med Commun 1997; 18: 118-121.
22. Fenlon HM, Phelan N, Tierney S, Gorey T, Ennis JT. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions. Clin Radiol 1998; 53: 17-24.
23. Obwegeser R, Berghammer P, Rodrigues M, Granegger S, Hohlagschwandtner M, Kucera H, et al. A head-to-head comparison between technetium-99m-tetrofosmin and technetium-99m-MIBI scintigraphy to evaluate suspicious breast lesions. Eur J Nucl Med 1999; 26: 1553-1559.
24. Ortapamuk H, Ozmen MM, Ibis S, Naldoken S, Aksoy F. Role of technetium scintimammography in the diagnosis of malignant breast masses and axillary lymph node involvement: a comparative study with mammography and histopathology. Eur J Surg 1999; 165: 1147-1153.
25. 99mTc-tetrofosmin SPET in both primary breast cancer and axillary lymph node metastasis detection. Eur J Nucl Med 2001; 28: 1781-1794.
26. 99mTc-tetrofosmin pinhole-SPECT in breast cancer axillary lymph node staging. Cancer Biother Radiopharm 2000; 15: 81-91.
27. Schillaci O, Scopinaro F, Spanu A, Connetti M, Danieli R, Di Luzio E, et al. Detection of axillary lymph node metastases in breast cancer with Tc-99m tetrofosmin scintigraphy. Int J Oncol 2002; 20: 483-487.
28. Rissanen TJ, Makarainen HP, Mattila SI, Lindholm EL, Heikkinen MI, Kiviniemi HO. Breast cancer recurrence after mastectomy: diagnosis with mammography and US. Radiology 1993; 188: 463-467.
29. Balu-Maestro C, Bruneton JN, Geoffray A, Chauvel C, Rogopoulos A, Hery MD. Ultrasonographic surveillance of treated breast cancer. J Radiol 1991; 72: 655-661.